Human pasteurized C1-inhibitor concentrate for the treatment of hereditary angioedema due to C1-inhibitor deficiency

References

• Quincke H. Über akutes umschriebenes Hautödem. Monatsh. Prakt. Dermatol.1, 129–131 (1882).
   Google Scholar
• Osler W. Hereditary angioneurotic edema. Am. J. Med. Sci.95, 362–367 (1888).
   Google Scholar
• Donaldson VH, Evans RR. A biochemical abnormality in hereditary angioneurotic edema: absence of serum inhibitor of C1-esterase. Am. J. Med.35, 37–44 (1963).
   PubMed Web of Science ®Google Scholar
• Rosen FS, Pensky J, Donaldson V, Charache P. Hereditary angioneurotic edema: two genetic variants. Science148, 957–958 (1965).
   PubMed Web of Science ®Google Scholar
• Bowen B, Hawk JJ, Sibunka S, Hovick S, Weiler JM. A review of the reported defects in the human C1 esterase inhibitor gene producing hereditary angioedema including four new mutations. Clin. Immunol.98, 157–163 (2001).
   PubMed Web of Science ®Google Scholar
• Kalmar L, Bors A, Farkas H et al. Mutation screening of the C1 inhibitor gene among Hungarian patients with hereditary angioedema. Hum. Mutat.22, 498 (2003).
   PubMedGoogle Scholar
• Agostoni A, Cicardi M. Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients. Medicine (Baltimore)71, 206–215 (1992).
   PubMed Web of Science ®Google Scholar
• Bork K, Barnstedt SE, Koch P, Traupe H. Hereditary angioedema with normal C1-inhibitor activity in women. Lancet356, 213–217 (2000).
   PubMed Web of Science ®Google Scholar
• Dewald G, Bork K. Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor. Biochem. Biophys. Res. Commun.343, 1286–1289 (2006).
   PubMed Web of Science ®Google Scholar
• Bork K. Hereditary angioedema with normal C1 inhibitor activity including hereditary angioedema with coagulation factor XII gene mutations. Immunol. Allergy Clin. North Am.26, 709–724 (2006).
   PubMed Web of Science ®Google Scholar
• Longhurst HJ, Bork K. Hereditary angioedema: causes, manifestations and treatment. Br. J. Hosp. Med. (Lond.)67, 654–657 (2006).
   PubMedGoogle Scholar
• Bork K, Staubach P, Eckardt AJ, Hardt J. Symptoms, course, and complications of abdominal attacks in hereditary angioedema due to C1 inhibitor deficiency. Am. J. Gastroenterol.101, 619–627 (2006).
   PubMed Web of Science ®Google Scholar
• Bork K, Meng G, Staubach P, Hardt J. Hereditary angioedema: new findings concerning symptoms, affected organs, and course. Am. J. Med.119, 267–274 (2006).
   PubMed Web of Science ®Google Scholar
• Bork K, Siedlecki K, Bosch S, Schopf RE, Kreuz W. Asphyxiation by laryngeal edema in patients with hereditary angioedema. Mayo Clin. Proc.75, 349–354 (2000).
   PubMed Web of Science ®Google Scholar
• Bork K, Barnstedt SE. Laryngeal edema and death from asphyxiation after tooth extraction in four patients with hereditary angioedema. J. Am. Dent. Assoc.134, 1088–1094 (2003).
   PubMed Web of Science ®Google Scholar
• Bowen T, Cicardi M, Farkas H et al. 2010 international consensus algorithm for the diagnosis, therapy and management of hereditary angioedema. Allergy Asthma Clin. Immunol.6, 24 (2010).
   PubMedGoogle Scholar
• Brackertz D, Kueppers F. Hereditary angioneurotic oedema. Lancet2, 680 (1973).
   PubMed Web of Science ®Google Scholar
• Gadek JE, Hosea SW, Gelfand JA et al. Replacement therapy in hereditary angioedema: successful treatment of acute episodes of angioedema with partly purified C1 inhibitor. N. Engl. J. Med.302, 542–546 (1980).
   PubMed Web of Science ®Google Scholar
• Waytes AT, Rosen FS, Frank MM. Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate. N. Engl. J. Med.334, 1630–1634 (1996).
   PubMed Web of Science ®Google Scholar
• Kunschak M, Engl W, Maritsch F et al. A randomized, controlled trial to study the efficacy and safety of C1 inhibitor concentrate in treating hereditary angioedema. Transfusion38, 540–549 (1998).
   PubMed Web of Science ®Google Scholar
• Visentin DE, Yang WH, Karsh J. C1-esterase inhibitor transfusions in patients with hereditary angioedema. Ann. Allergy Asthma Immunol.80, 457–461 (1998).
   PubMedGoogle Scholar
• Bork K, Barnstedt SE. Treatment of 193 episodes of laryngeal edema with C1 inhibitor concentrate in patients with hereditary angioedema. Arch. Intern. Med.161, 714–718 (2001).
   PubMed Web of Science ®Google Scholar
• Bork K, Meng G, Staubach P, Hardt J. Treatment with C1 inhibitor concentrate in abdominal pain attacks of patients with hereditary angioedema. Transfusion45, 1774–1784 (2005).
   PubMed Web of Science ®Google Scholar
• Levi M, Choi G, Picavet C, Hack CE. Self-administration of C1-inhibitor concentrate in patients with hereditary or acquired angioedema caused by C1-inhibitor deficiency. J. Allergy Clin. Immunol.117, 904–908 (2006).
   PubMed Web of Science ®Google Scholar
• Gompels MM, Lock RJ, Abinun M et al. C1 inhibitor deficiency: consensus document. Clin. Exp. Immunol.139, 379–394 (2005).
   PubMed Web of Science ®Google Scholar
• Bork K, Frank J, Grundt B, Schlattmann P, Nussberger J, Kreuz W. Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant). J. Allergy Clin. Immunol.119, 1497–1503 (2007).
   PubMed Web of Science ®Google Scholar
• Cicardi M, Banerji A, Bracho F et al. Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema. N. Engl. J. Med.363, 532–541 (2010).
   PubMed Web of Science ®Google Scholar
• Zuraw B, Cicardi M, Levy RJ et al. Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema. J. Allergy Clin. Immunol.126, 821–827 (2010).
   PubMed Web of Science ®Google Scholar
• Cicardi M, Levy RJ, McNeil DL et al. Ecallantide for the treatment of acute attacks in hereditary angioedema. N. Engl. J. Med.363, 523–531 (2010).
   PubMed Web of Science ®Google Scholar
• Farkas H, Gyeney L, Gidofalvy E, Fust G, Varga L. The efficacy of short-term danazol prophylaxis in hereditary angioedema patients undergoing maxillofacial and dental procedures. J. Oral Maxillofac. Surg.57, 404–408 (1999).
   PubMed Web of Science ®Google Scholar
• Gelfand JA, Sherins RJ, Alling DW, Frank MM. Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities. N. Engl. J. Med.295, 1444–1448 (1976).
   PubMed Web of Science ®Google Scholar
• Cicardi M, Bergamaschini L, Cugno M, Hack E, Agostoni G, Agostoni A. Long-term treatment of hereditary angioedema with attenuated androgens: a survey of a 13-year experience. J. Allergy Clin. Immunol.87, 768–773 (1991).
   PubMed Web of Science ®Google Scholar
• Frank MM. Hereditary angioedema: the clinical syndrome and its management in the United States. Immunol. Allergy Clin. North Am.26, 653–668 (2006).
   PubMed Web of Science ®Google Scholar
• Bork K, Bygum A, Hardt J. Benefits and risks of danazol in hereditary angioedema: a long-term survey of 118 patients. Ann. Allergy Asthma Immunol.100, 153–161 (2008).
   PubMed Web of Science ®Google Scholar
• Cicardi M, Castelli R, Zingale LC, Agostoni A. Side effects of long-term prophylaxis with attenuated androgens in hereditary angioedema: comparison of treated and untreated patients. J. Allergy Clin. Immunol.99, 194–196 (1997).
   PubMed Web of Science ®Google Scholar
• Zurlo JJ, Frank MM. The long-term safety of danazol in women with hereditary angioedema. Fertil. Steril.54, 64–72 (1990).
   PubMed Web of Science ®Google Scholar
• Bork K, Schneiders V. Danazol-induced hepatocellular adenoma in patients with hereditary angio-oedema. J. Hepatol.36, 707–709 (2002).
   PubMed Web of Science ®Google Scholar
• Szeplaki G, Varga L, Valentin S et al. Adverse effects of danazol prophylaxis on the lipid profiles of patients with hereditary angioedema. J. Allergy Clin. Immunol.115, 864–869 (2005).
   PubMed Web of Science ®Google Scholar
• Sheffer AL, Austen KF, Rosen FS. Tranexamic acid therapy in hereditary angioneurotic edema. N. Engl. J. Med.287, 452–454 (1972).
   PubMed Web of Science ®Google Scholar
• Zuraw BL, Busse PJ, White M et al. Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema. N. Engl. J. Med.363, 513–522 (2010).
   PubMed Web of Science ®Google Scholar
• De Serres J, Groner A, Lindner J. Safety and efficacy of pasteurized C1 inhibitor concentrate (Berinert P) in hereditary angioedema: a review. Transfus. Apher. Sci.29, 247–254 (2003).
   PubMed Web of Science ®Google Scholar
• Groener A, Nowak T, Schäfer W. An integrate approach to effective pathogen reduction for a plasma-derived C1-inhibitor concentrate. Haemostaseologie28, A96 (2008).
   Google Scholar
• Martinez-Saguer I, Rusicke E, Aygoren-Pursun E, von Hentig N, Klingebiel T, Kreuz W. Pharmacokinetic analysis of human plasma-derived pasteurized C1-inhibitor concentrate in adults and children with hereditary angioedema: a prospective study. Transfusion50, 354–360 (2010).
   PubMed Web of Science ®Google Scholar
• Bernstein JA, Ritchie B, Levy RJ et al. Populaton pharmacokinetics of plasma-derived C1 esterase inhibitor concentrate used to treat acute hereditary angioedema attacks. Ann. Allergy Asthma Immunol.105, 149–154 (2010).
   PubMed Web of Science ®Google Scholar
• Bork K, Hardt J, Schicketanz KH, Ressel N. Clinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiency. Arch. Intern. Med.163, 1229–1235 (2003).
   PubMed Web of Science ®Google Scholar
• Bork K, Koch P. Episodes of severe dyspnea caused by snoring-induced recurrent edema of the soft palate in hereditary angioedema. J. Am. Acad. Dermatol.45, 968–969 (2001).
   PubMedGoogle Scholar
• Farkas H, Jakab L, Temesszentandrasi G et al. Hereditary angioedema: a decade of human C1-inhibitor concentrate therapy. J. Allergy Clin. Immunol.20, 941–947 (2007).
   Google Scholar
• Bork K, Staubach P, Hardt J. Treatment of skin swellings with C1-inhibitor concentrate in patients with hereditary angio-oedema. Allergy63, 751–757 (2008).
   PubMed Web of Science ®Google Scholar
• Kreuz W, Martinez-Saguer I, Aygoren-Pursun E, Rusicke E, Heller C, Klingebiel T. C1-inhibitor concentrate for individual replacement therapy in patients with severe hereditary angioedema refractory to danazol prophylaxis. Transfusion49, 1987–1995 (2009).
   PubMed Web of Science ®Google Scholar
• Zanichelli A, Vacchini R, Badini M, Penna V, Cicardi M. Standard care impact on angioedema because of hereditary C1 inhibitor deficiency: a 21-month prospective study in a cohort of 103 patients. Allergy66, 192–196 (2011).
   PubMed Web of Science ®Google Scholar
• Craig TJ, Levy RJ, Wasserman RL et al. Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks. J. Allergy Clin. Immunol.124, 801–808 (2009).
   PubMed Web of Science ®Google Scholar
• Craig TJ, Wasserman RL, Levy RJ et al. Prospective study of rapid relief provided by C1 esterase inhibitor in emergency treatment of acute laryngeal attacks in hereditary angioedema. J. Clin. Immunol.30, 823–829 (2010).
   PubMed Web of Science ®Google Scholar
• Wasserman RL, Levy RJ, Bewtra AK et al. Prospective study of C1 esterase inhibitor in the treatment of successive acute abdominal and facial hereditary angioedema attacks. Ann. Allergy Asthma Immunol.106, 62–68 (2011).
   Google Scholar
• Bygum A, Andersen KE, Mikkelsen CS. Self-administration of intravenous C1-inhibitor therapy for hereditary angioedema and associated quality of life benefits. Eur. J. Dermatol.19, 147–151 (2009).
   PubMed Web of Science ®Google Scholar
• Longhurst HJ, Farkas H, Craig T et al. HAE international home therapy consensus document. Allergy Asthma Clin. Immunol.6, 22 (2010).
   PubMedGoogle Scholar
• Farkas H, Harmat G, Fust G, Varga L, Visy B. Clinical management of hereditary angio-oedema in children. Pediatr. Allergy Immunol.13, 153–161 (2002).
   PubMed Web of Science ®Google Scholar
• Czaller I, Visy B, Csuka D, Fust G, Toth F, Farkas H. The natural history of hereditary angioedema and the impact of treatment with human C1-inhibitor concentrate during pregnancy: a long-term survey. Eur. J. Obstet. Gynecol. Reprod. Biol.152, 44–49 (2010).
   PubMed Web of Science ®Google Scholar
• Martinez-Saguer I, Rusicke E, Aygoren-Pursun E, Heller C, Klingebiel T, Kreuz W. Characterization of acute hereditary angioedema attacks during pregnancy and breast-feeding and their treatment with C1 inhibitor concentrate. Am. J. Obstet. Gynecol.203, 131–137 (2010).
   Google Scholar
• Leimgruber A, Jaques WA, Spaeth PJ. Hereditary angioedema: uncomplicated maxillofacial surgery using short-term C1 inhibitor replacement therapy. Int. Arch. Allergy Immunol.101, 107–112 (1993).
   PubMed Web of Science ®Google Scholar
• Langton D, Weiner J, Fary W. C1-esterase inhibitor concentrate prevents upper airway obstruction in hereditary angio-oedema. Med. J. Aust.160, 383–384 (1994).
   PubMedGoogle Scholar
• Maves KK, Weiler JM. Tonsillectomy in a patient with hereditary angioedema after prophylaxis with C1 inhibitor concentrate. Ann. Allergy73, 435–438 (1994).
   PubMedGoogle Scholar
• Mohr M, Pollok-Kopp B, Gotze O, Burchardi H. The use of a C1-inhibior concentrate for short-term preoperative prophylaxis in two patients with hereditary angioedema. Anaesthesist45, 626–630 (1996).
   PubMed Web of Science ®Google Scholar
• Lehmann A, Lang J, Boldt J, Saggau W. Successful off-pump coronary artery bypass graft surgery in a patient with hereditary angioedema. J. Cardiothorac. Vasc. Anesth.16, 473–476 (2002).
   PubMed Web of Science ®Google Scholar
• Bork K, Hardt J, Staubach-Renz P, Witzke G. Risk of laryngeal edema and facial swellings following tooth extraction in patients with hereditary angioedema with and without prophylaxis with C1-INH concentrate; a retrospective study. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.112, 58–64 (2011).
   PubMed Web of Science ®Google Scholar
• Bork K, Witzke G. Long-term prophylaxis with C1-inhibitor (C1 INH) concentrate in patients with recurrent angioedema caused by hereditary and acquired C1-inhibitor deficiency. J. Allergy Clin. Immunol.83, 677–682 (1989).
   PubMed Web of Science ®Google Scholar
• Martinez-Saguer I, Heller C, Fischer D, Ettingshausen CE, Kreuz W. Prophylactic treatment with pasteurised C1 inhibitor in hereditary angioedema (HAE) – a prospective 32 months follow up. Blood94(Suppl. 1), 2339 (1999) (Abstract 1032).
   Google Scholar
• Tallroth GA. Long-term prophylaxis of hereditary angioedema with a pasteurized C1 inhibitor concentrate. Int. Arch. Allergy Immunol.154, 356–359 (2011).
   Google Scholar
• Hermans C. Successful management with C1-inhibitor concentrate of hereditary angioedema attacks during two successive pregnancies: a case report. Arch. Gynecol. Obstet.276, 271–276 (2007).
   PubMedGoogle Scholar
• Bork K, Hardt J. Hereditary angioedema: long-term treatment with one or more injections of C1 inhibitor concentrate per week. Int. Arch. Allergy Immunol.154, 81–88 (2011).
   PubMed Web of Science ®Google Scholar
• Klarmann D, Kreuz W, Joseph-Steiner J, Ehrenforth S. Hepatitis C and pasteurized C1-inhibitor concentrate. Transfusion36, 84–85 (1996).
   PubMedGoogle Scholar
• Bork K. Prospective virus safety follow-up after therapy with a pasteurised C1 inhibitor concentrate. Biomed. Progr.2, 59–61 (1992).
   Google Scholar
• Bork K, Fremann S, Kreuz W. Long-term safety of C1 inhibitor concentrate in the treatment of acute hereditary angioedema attacks. Allergy65, 204 (2010) (Abstract 506).
   Google Scholar
• Bork K, Hardt J. Hereditary angioedema: increased number of attacks after frequent treatments with C1 inhibitor concentrate. Am. J. Med.122, 780–783 (2009).
   Google Scholar
• Cicardi M, Bergamaschini L, Marasini B, Boccassini G, Tucci A, Agostoni A. Hereditary angioedema: an appraisal of 104 cases. Am. J. Med. Sci.284, 2–9 (1982).
   PubMed Web of Science ®Google Scholar
• Cicardi M, Zingale L. How do we treat patients with hereditary angioedema. Transfus. Apher. Sci.29, 221–227 (2003).
   PubMed Web of Science ®Google Scholar